Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-199,295
Closed -$2.17M 151
2025
Q2
$2.17M Buy
199,295
+1,132
+0.6% +$12.7K 0.4% 50
2025
Q1
$2.47M Buy
198,163
+52,508
+36% +$865K 0.52% 38
2024
Q4
$2.88M Sell
145,655
-2,039
-1% -$22.6K 0.64% 33
2024
Q3
$1.01M Hold
147,694
0.24% 83
2024
Q2
$1.01M Buy
147,694
+7,942
+6% +$54.3K 0.23% 87
2024
Q1
$700K Buy
139,752
+124,246
+801% +$265K 0.18% 100
2023
Q4
$34.1K Buy
15,506
+1,501
+11% +$3.58K 0.01% 187
2023
Q3
$34.5K Buy
14,005
+1,400
+11% +$6.69K 0.01% 178
2023
Q2
$98.6K Buy
12,605
+3,499
+38% +$25K 0.02% 265
2023
Q1
$59.9K Buy
9,106
+201
+2% +$1.33K 0.02% 257
2022
Q4
$39.5K Buy
8,905
+1,331
+18% +$8.32K 0.01% 238
2022
Q3
$42K Sell
7,574
-1,331
-15% -$8.04K 0.01% 240
2022
Q2
$39K Buy
8,905
+1,500
+20% +$10.3K 0.01% 239
2022
Q1
$60K Buy
+7,405
New +$63K 0.01% 246

Other funds holding MESO

Summit X LLC's MESO Position: Q3 2025 in Review

Summit X LLC sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 199,295 shares — an estimated $2.17M sold.

Summit X LLC first reported a position in MESO in Q1 2022 and held it in 14 quarters. The position peaked at $2.88M in Q4 2024. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

  • Summit X LLC reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 199,295 Mesoblast shares in Q3 2025, an estimated $2.17M.
  • Summit X LLC first reported a position in Mesoblast in Q1 2022 and held it in 14 quarters.
  • Summit X LLC's Mesoblast position peaked at $2.88M in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.